Stocklytics Platform
Asset logo for symbol AMPH
Amphastar Pharmaceuticals
AMPH87
$38.27arrow_drop_down2.24%-$0.87
High Quality
Asset logo for symbol AMPH
AMPH87

$38.27

arrow_drop_down2.24%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Amphastar Pharmaceuticals (AMPH) Stocklytics Forecast

According to our AI and machine learning algorithms, the stock forecast for Amphastar Pharmaceuticals Inc (AMPH) shows promising potential. Historical data and market trends indicate positive growth for the company in the coming years. Based on our analysis, we predict that the stock price of AMPH will see a steady increase in the next few years. As per our forecast for 2023, AMPH stock is expected to reach new highs.
Multiple analysts have also provided positive price targets for AMPH. The average price target for Amphastar Pharmaceuticals Inc, according to analysts, is expected to reach a significant level by 2023. The company's performance, market position, and future prospects have contributed to these optimistic projections. It is important to note that analyst ratings for AMPH stock have also been favorable, indicating a good potential for investment. Considering these factors, AMPH stock appears to be a promising buy in the current market scenario.
add Amphastar Pharmaceuticals  to watchlist

Keep an eye on Amphastar Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Amphastar Pharmaceuticals (AMPH) stock?

Analysts have set a target price of $38.92 for Amphastar Pharmaceuticals (AMPH), based on forecasts from 13 analysts. The predicted price range extends from a high of $70 to a low of $17. This represents a potential increase of up to 82.91% and a decrease of -55.58% from the current price of $38.27. These forecasts are as of 2015 Jun 03.
help

What are the analyst ratings for Amphastar Pharmaceuticals (AMPH) stock?

The analyst ratings for Amphastar Pharmaceuticals (AMPH) are distributed as follows: 4 analysts recommend buying, 2 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 6 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Amphastar Pharmaceuticals .
help

What is the AI price prediction for Amphastar Pharmaceuticals (AMPH) stock?

At present, there is no AI or machine-learning-based price prediction available for Amphastar Pharmaceuticals (AMPH) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level